SCHEMBL489623

SCHEMBL489623

CO[C@@H](CC=O)[C@@H](O)[C@@H](C)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29389985 1.00
SCHEMBL167035 1.00
SCHEMBL27926682 1.00
SCHEMBL182616 1.00
SCHEMBL7145815 0.79
SCHEMBL2316300 0.79 LMNA (0.39)
SCHEMBL11152736 0.78 TSHR (0.38)
SCHEMBL3361989 0.76
SCHEMBL2318068 0.76
SCHEMBL1389456 0.74 AKR1B1 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 500 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119999789-A Enzymatic fermentation-based method for cooking powder of leaf-substituted Matcha of Piper sarmentosum and roasted eel with tea 中国海洋大学 2025-05-16 CN claimed
WO-2025083657-A1 LIPID COMPOUND AND COMPOSITION FOR TISSUE-SPECIFIC DELIVERY OF ACTIVE SUBSTANCE 한국생명공학연구원 2025-04-24 WO claimed
WO-2024259191-A2 METHOD AND COMPOSITIONS FOR TREATING SKIN DISORDERS PHOENIX BIOTECHNOLOGY, INC. (US) 2024-12-19 WO claimed
US-20240261312-A1 Method and compositions for treating animal viral infections PHOENIX BIOTECHNOLOGY, INC. (US) 2024-08-08 US claimed
EP-4387627-A1 METHOD AND COMPOSITIONS FOR TREATING ANIMAL VIRAL INFECTIONS Phoenix Biotechnology, Inc. (US) 2024-06-26 EP claimed
WO-2023235807-A2 METHOD AND COMPOSITIONS FOR TREATING GLIOBLASTOMA WITH TRITERPENES PHOENIX BIOTECHNOLOGY, INC. (US) 2023-12-07 WO claimed
EP-4009981-B1 METHOD AND COMPOSITIONS FOR TREATING CORONAVIRUS INFECTION PHOENIX BIOTECHNOLOGY INC (US) 2023-08-16 EP claimed
WO-2023022866-A1 METHOD AND COMPOSITIONS FOR TREATING ANIMAL VIRAL INFECTIONS PHOENIX BIOTECHNOLOGY, INC. (US) 2023-02-23 WO claimed
CN-115624035-A Piper sarmentosum bunge extract and preparation method and application thereof 保亭海农农业开发有限公司 2023-01-20 CN claimed
CN-115606698-A Feed additive for preventing and treating digestive tract diseases of black goats and preparation method thereof 贵州省畜牧兽医研究所 2023-01-17 CN claimed
CN-104974880-A Traditional Chinese herbal medicine liquor cake formula suitable for brewing common health-caring liquor YAN ZHIFU 2015-10-14 CN claimed
CN-103584195-A Fermented favor melon seed powder and preparation method thereof HEFEI HAOKANG FOOD TRADE CO LTD 2014-02-19 CN claimed
CN-103549533-A Baked flavor crispy lard oil shelled melon seeds and preparation method thereof HEFEI HAOKANG FOODS TRADE CO LTD 2014-02-05 CN claimed
CN-103549543-A Melon seed powder rich in anthocyanin and preparation method thereof HEFEI HAOKANG FOODS TRADE CO LTD 2014-02-05 CN claimed
CN-103549542-A Sweet potato melon seed powder and preparation method thereof HEFEI HAOKANG FOODS TRADE CO LTD 2014-02-05 CN claimed
CN-103549536-A Yogurt-flavored melon seed powder and preparation method thereof HEFEI HAOKANG FOODS TRADE CO LTD 2014-02-05 CN claimed
US-7538092-B2 Pharmaceutically active oligosaccharide conjugates FRESENIUS KABI DEUTSCHLAND GMBH (DE) 2009-05-26 US claimed
EP-1549350-B1 PHARMACEUTICALLY ACTIVE OLIGOSACCHARIDE CONJUGATES FRESENIUS KABI DE GMBH (DE) 2008-09-24 EP claimed
US-20060100163-A1 Pharmaceutically active oligosaccharide conjugates FRESENIUS KABI DEUTSCHLAND GMBH (DE) 2006-05-11 US claimed
US-3963697-A Labelled cardiotonic glycosides for use in radioimmunoassay CURTIS NUCLEAR CORPORATION (US) 1976-06-15 US claimed